Apixaban for Extended Treatment of Venous Thromboembolism

Agnelli, Giancarlo; R. Büller, Harry; T. Cohen, Alexander; Curto, Madelyn; Gallus, Alexander; Johnson, Margot; R. Porcari, Anthony; E. Raskob, Gary; I. Weitz, Jeffrey

doi:10.1056/nejmoa1207541

Public

Apixaban for Extended Treatment of Venous Thromboembolism

Published in New England Journal of Medicine • Dec 8, 2012

Authors:

Giancarlo Agnelli

Harry R. Büller

Alexander T. Cohen

Abstract

BACKGROUND: Apixaban, an oral factor Xa inhibitor that can be administered in a simple, fixed-dose regimen, may be an option for the extended treatment of venous thromboembolism. METHODS: In this randomized, double-blind study, we compared two doses of apixaban (2.5 mg and 5 mg, twice daily) with pl...

Subject

Apixaban

Venous thromboembolism

Medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!